Amedeo Smart

Free Medical Literature Service

 

Amedeo

Dermatology
  Free Subscription

01.12.2025

1 Am J Pathol
11 BMC Cancer
9 Br J Dermatol
1 Cancer Lett
14 Clin Exp Dermatol
16 Eur J Dermatol
5 Int J Dermatol
3 J Cutan Pathol
9 J Dermatol
10 J Invest Dermatol
2 Lancet
2 Mycoses
1 Plast Reconstr Surg
1 PLoS Biol
5 PLoS One


    Am J Pathol

  1. ACCATTATIS FM, Gelsomino L, Manna L, Del Console P, et al
    Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor-positive Breast Cancer Cells.
    Am J Pathol. 2025 Sep 12:S0002-9440(25)00336.
    >> Share


    BMC Cancer

  2. SPERLICH S, Geyer S, Holthausen-Markou S, Park-Simon TW, et al
    Breast cancer survivors' participation in social activities five years after primary surgery - are there social inequalities?
    BMC Cancer. 2025;25:1829.
    >> Share

  3. COELHO LL, Vianna MM, da Silva DM, Gonzaga BMS, et al
    beta-lapachone impairs viability, migration, and epithelial-mesenchymal transition in mammary tumor spheroids.
    BMC Cancer. 2025;25:1826.
    >> Share

  4. DENG Z, Li Y, Luo Y, Cao X, et al
    Nomogram models for prediction of axillary lymph node metastasis in breast cancer patients.
    BMC Cancer. 2025;25:1827.
    >> Share

  5. YUAN S, Li J, Liu W, Ren M, et al
    CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis.
    BMC Cancer. 2025;25:1828.
    >> Share

  6. ZHAO M, Zhao L, Yang Y, Wang F, et al
    Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.
    BMC Cancer. 2025;25:1808.
    >> Share

  7. OJEDELE OA, Hamdi N, Mughram MHA, Alyami EM, et al
    Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling.
    BMC Cancer. 2025;25:1812.
    >> Share

  8. ZHANG H, Yin X, Wang S, Li Q, et al
    Combined elevation of myeloid-derived suppressor cells and Tregs predicts lymph node metastasis in breast cancer.
    BMC Cancer. 2025;25:1806.
    >> Share

  9. SHAWANA S, Mirza T, Khatoon A, Mushtaq S, et al
    Uncovering rare somatic variants in olfactory receptor genes in Pakistani triple-negative breast cancer patients.
    BMC Cancer. 2025;25:1799.
    >> Share

  10. WANG A, Zeng P, Ma T, Shi H, et al
    Establishment of a new method for detection of TROP2-positive circulating tumor cells in breast cancer.
    BMC Cancer. 2025;25:1797.
    >> Share

  11. YAN X, Zhang X, Wang Z, Yang L, et al
    Safety and efficacy of immune checkpoint inhibitors in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1804.
    >> Share

  12. BUJA A, Cassalia F, Rugge M, Trevisiol C, et al
    Impact of comorbidities on survival in melanoma patients.
    BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15376.
    >> Share


    Br J Dermatol

  13. ZHAO M, Xu Z, Wu L, Wei Z, et al
    Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial.
    Br J Dermatol. 2025 Nov 24:ljaf455. doi: 10.1093.
    >> Share

  14. XIANG Z, Chen G, Yin L, Xi X, et al
    Cutaneous toxicity and management in CEA-targeted Chimeric Antigen Receptor T-cell therapy for solid tumors.
    Br J Dermatol. 2025 Nov 24:ljaf473. doi: 10.1093.
    >> Share

  15. CHENG AY, Lin CC, Cheng AT, Chou MP, et al
    Incidence of skin cancer versus overall de novo malignancies among living donor liver transplant recipients in Taiwan: a cohort study.
    Br J Dermatol. 2025 Nov 24:ljaf472. doi: 10.1093.
    >> Share

  16. STERN R
    Cancer and Psoriasis: Known Risk factors explain the Association.
    Br J Dermatol. 2025 Nov 25:ljaf477. doi: 10.1093.
    >> Share

  17. FERTITTA L, Sarin KY, Romo CG, Bergqvist C, et al
    Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-D.
    Br J Dermatol. 2025 Nov 26:ljaf479. doi: 10.1093.
    >> Share

  18. MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
    Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden.
    Br J Dermatol. 2025 Nov 26:ljaf478. doi: 10.1093.
    >> Share

  19. GOMEZ-TOMAS A, Gonzalez-Cruz C, Garcia-Patos V, Ferrandiz-Pulido C, et al
    Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients.
    Br J Dermatol. 2025 Nov 27:ljaf483. doi: 10.1093.
    >> Share

  20. KNOPFEL N, Barberan-Martin S, Polubothu S, Sauvadet A, et al
    Gene discovery in extensive dermal melanocytosis reveals multiple mosaic causes.
    Br J Dermatol. 2025 Nov 27:ljaf481. doi: 10.1093.
    >> Share

  21. MILTNER LA, Loman L, Ortiz JA, Zhang J, et al
    Multimorbidity and Atopic Dermatitis in a Population-Based Cohort: Severity-Dependent Association With Distinct Non-Atopic Multimorbidity Patterns.
    Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093.
    >> Share


    Cancer Lett

  22. KRAWCZYNSKA N, Wang Y, Lim K, Das Gupta A, et al
    Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells.
    Cancer Lett. 2025 Oct 28:218105. doi: 10.1016/j.canlet.2025.218105.
    >> Share


    Clin Exp Dermatol

  23. CLARKE E, van Bodegraven B, Shipman AR
    Does ciclosporin cause symptomatic hypomagnesaemia in psoriasis patients included in the British Association of Dermatologists Biologics and Immunomodulators Registry (BADBIR) pharmacovigilance registry?
    Clin Exp Dermatol. 2025 Nov 21:llaf520. doi: 10.1093.
    >> Share

  24. YAO H, Wu Y, Li J, Zhang R, et al
    Hypereosinophilic dermatitis misdiagnosed as chronic eczema in an elderly male with multiple comorbidities.
    Clin Exp Dermatol. 2025 Nov 25:llaf512. doi: 10.1093.
    >> Share

  25. SILVA I, Miriyala S, Khattri S
    Efficacy and response of the use of biologic and small-molecule combination therapy in adults with atopic dermatitis.
    Clin Exp Dermatol. 2025;50:2493-2495.
    >> Share

  26. HUA S, Fang B, Liu Y, Hu Z, et al
    A novel missense mutation responsible for a unique erythrokeratodermia variabilis patient with skin lesions in a swirling pattern.
    Clin Exp Dermatol. 2025 Nov 26:llaf510. doi: 10.1093.
    >> Share

  27. YAN Y, Wang D, Wang P, Wu Y, et al
    Effect of 5-aminolaevulinic acid photodynamic therapy followed by sequential 30% supramolecular salicylic acid treatment in moderate-to-severe acne vulgaris: a prospective, randomized, split-face controlled study.
    Clin Exp Dermatol. 2025;50:2439-2447.
    >> Share

  28. SIN-SOLER M, Louka M, Garbayo-Salmons P, Torrelo A, et al
    Hidradenitis suppurativa in paediatric patients with Down syndrome: a comparative study of 116 participants.
    Clin Exp Dermatol. 2025;50:2418-2424.
    >> Share

  29. OLSHINKA A, Harris Rimon G, Lapidoth M, Mimouni D, et al
    Pyogenic granuloma-like Spitz naevus in paediatric patients: a case series.
    Clin Exp Dermatol. 2025;50:2392-2396.
    >> Share

  30. SEARLE T, Al-Niaimi F, Ali FR
    Modulation of the microbiome: a paradigm shift in the treatment of acne.
    Clin Exp Dermatol. 2025;50:2357-2364.
    >> Share

  31. JIANG X, Lai W, Gao X, Zeng W, et al
    Efficacy and safety of supramolecular salicylic acid in the treatment of papulopustular rosacea: a multicentre randomized, double-blind, placebo-controlled superiority study.
    Clin Exp Dermatol. 2025;50:2410-2417.
    >> Share

  32. OTA VK, Mariath LM, Torrelio RMF, Arashiro CS, et al
    Genetic profiling of epidermolysis bullosa in a large Brazilian cohort.
    Clin Exp Dermatol. 2025;50:2397-2409.
    >> Share

  33. SHEERN C, Levell NJ, Craig PJ, Jeffrey P, et al
    Mycosis fungoides: a review.
    Clin Exp Dermatol. 2025;50:2365-2375.
    >> Share

  34. VYAS J, Johns JR, Trivedi A, Ali FM, et al
    Systematic review of the use of the Dermatology Life Quality Index in routine clinical practice: evidence from 287 articles across 56 countries.
    Clin Exp Dermatol. 2025;50:2456-2465.
    >> Share

  35. ERAIFEJ N, Jupe T, Grundmann A, Blythe A, et al
    Exploring the use of instructional dermatology surface models within a dermatology-focused objective structured clinical examination station for medical students.
    Clin Exp Dermatol. 2025;50:2473-2477.
    >> Share

  36. WARREN Z, West C, Sander C, Lai FYX, et al
    TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib.
    Clin Exp Dermatol. 2025;50:2482-2485.
    >> Share


    Eur J Dermatol

  37. MUNEISHI Y, Oyama N, Hasegawa M
    A paediatric case of solitary cutaneous mastocytoma with progression to urticaria pigmentosa: phenotypic transition or dual phenotype?
    Eur J Dermatol. 2025;35:410-411.
    >> Share

  38. MUNCEY-BUCKLEY M, Chin G, Brocklehurst P, Morton C, et al
    Identification and prioritisation of skin cancer-related use cases for dermatological artificial intelligence tools.
    Eur J Dermatol. 2025;35:413-415.
    >> Share

  39. SUZUKI Y, Yanagisawa H, Jin L, Arai E, et al
    Polypoid basal cell carcinoma arising in the inguinal region.
    Eur J Dermatol. 2025;35:415-417.
    >> Share

  40. TOYOSHIMA M, Nakaoji K, Hamada K, Yamanaka A, et al
    Analysis of skin aging patterns using a facial imaging system in atopic dermatitis patients of 20-34 years old.
    Eur J Dermatol. 2025;35:424-426.
    >> Share

  41. FUKAI R, Hamaguchi Y, Kitano T, Komatsu N, et al
    Severe relapse of cutaneous polyarteritis nodosa triggered by bacterial cellulitis.
    Eur J Dermatol. 2025;35:427-429.
    >> Share

  42. SAKIYAMA T, Furuta K
    Rare coexistence of generalized pustular psoriasis and discoid lupus erythematosus with worsening of lupus lesions after bimekizumab therapy: a case report.
    Eur J Dermatol. 2025;35:432-433.
    >> Share

  43. HIOKI T, Kamiya H, Hayano K, Kuze B, et al
    Concurrent granulomatous skin and nasal lesions likely induced by adalimumab for ulcerative colitis: a unique case of localized drug-induced granulomatosis.
    Eur J Dermatol. 2025;35:433-435.
    >> Share

  44. GONZALEZ JM, Sanchez BR, Briones LJ, Goller S, et al
    Journal Club. Genetic pathways in melanoma: molecular foundations and clinical implications.
    Eur J Dermatol. 2025;35:442-444.
    >> Share

  45. BRIONES LJ, Sanchez BR, Piqueras PG, Parra V, et al
    Childhood lupus erythematosus panniculitis.
    Eur J Dermatol. 2025;35:445-446.
    >> Share

  46. FERREIRA CS, Sousa M, Contente M, Torres T, et al
    Successful use of risankizumab in a patient with severe psoriasis and active lung adenocarcinoma.
    Eur J Dermatol. 2025;35:446-448.
    >> Share

  47. ZAVATTARO E, Airoldi C, Veronese F, Cammarata E, et al
    From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaign.
    Eur J Dermatol. 2025;35:361-368.
    >> Share

  48. PRIMERANO A, Floriddia G, De Domenico E, Collina MC, et al
    Localized dominant dystrophic epidermolysis bullosa worsened by diabetes.
    Eur J Dermatol. 2025;35:369-376.
    >> Share

  49. AN Q, Li K, Yang B
    Association between stem cell growth factor beta and fibrotic skin diseases.
    Eur J Dermatol. 2025;35:377-386.
    >> Share

  50. BEYRON A
    Keratosis pilaris: a systematic review of the literature and strategies for optimal treatment.
    Eur J Dermatol. 2025;35:387-393.
    >> Share

  51. CHEN G, Zhang Y, Cui M, Li H, et al
    Co-occurrence of two monogenic diseases within a single family.
    Eur J Dermatol. 2025;35:394-400.
    >> Share

  52. LI Y, Zeng Q, Cao QY, Zhao AQ, et al
    Hypohidrotic ectodermal dysplasia: association between EDA mutations and hypotrichosis - a case series.
    Eur J Dermatol. 2025;35:401-407.
    >> Share


    Int J Dermatol

  53. ZHAO Y, Zhang L, Wu L, Yang B, et al
    Efficacy and Safety of Anti-IL-4Ralpha Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis.
    Int J Dermatol. 2025 Nov 21. doi: 10.1111/ijd.70175.
    >> Share

  54. MORTAZAVI H, Firooz A, Khatami A, Khamesipour A, et al
    Erysipeloid Cutaneous Leishmaniasis in the Old World: A Systematic Review.
    Int J Dermatol. 2025 Nov 26. doi: 10.1111/ijd.70142.
    >> Share

  55. BRIATICO G, Scharf C, Nicoletti MM, Petti A, et al
    Comparison of Clinical and Dermoscopic Features Between Micronodular and Nodular Basal Cell Carcinoma.
    Int J Dermatol. 2025 Nov 26. doi: 10.1111/ijd.70163.
    >> Share

  56. ARMARIO-HITA JC, Galan-Gutierrez M, Pereyra-Rodriguez JJ, Suarez-Perez J, et al
    Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain.
    Int J Dermatol. 2025 Nov 27. doi: 10.1111/ijd.70185.
    >> Share

  57. ROB F, Kojanova M, Hercogova JT, Balaz M, et al
    Efficacy and Safety Evaluation of Different Lebrikizumab Dosages in Atopic Dermatitis Patients Over 16 to 24 Weeks: A BIOREP Registry Analysis.
    Int J Dermatol. 2025 Nov 28. doi: 10.1111/ijd.70180.
    >> Share


    J Cutan Pathol

  58. CHENG A, Gruchy J, Burns A, Langley R, et al
    Deep Dermal and Subcutaneous Deposits in Thin Melanoma: A Cautionary Tale.
    J Cutan Pathol. 2025 Nov 27. doi: 10.1111/cup.70025.
    >> Share

  59. HULSE J, Swanson A, O'Donnell E, Fraga G, et al
    Diagnostic Accuracy of Immunohistochemistry Testing on Sebaceous Gland Neoplasms for Muir-Torre Syndrome: A Meta-Analysis.
    J Cutan Pathol. 2025 Nov 27. doi: 10.1111/cup.70026.
    >> Share

  60. WANG X, Huang Y
    The Diagnostic Value of Autofluorescence in Hematoxylin-Eosin-Stained Sections for Cutaneous Sporotrichosis.
    J Cutan Pathol. 2025 Nov 24. doi: 10.1111/cup.70022.
    >> Share


    J Dermatol

  61. MINAKAWA S, Matsuzaki Y, Hashimoto T, Ishii N, et al
    Lichenoid Drug Eruption due to Telmisartan-Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70068.
    >> Share

  62. OKAZAKI T, Terui H, Takahashi T, Kobayashi A, et al
    Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single Center.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70069.
    >> Share

  63. KATAYAMA S, Nishihara K, Kohri N, Yoshida S, et al
    Successful Treatment of BRAF(V600R)-Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF/MEK Inhibitors.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70080.
    >> Share

  64. IRIE K, Yamamoto M, Yamamoto T
    Disseminated Fibrous Papules of the Lip.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70064.
    >> Share

  65. TOYOSHIMA R, Aso S, Matsui H, Fushimi K, et al
    Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database.
    J Dermatol. 2025 Nov 26. doi: 10.1111/1346-8138.70082.
    >> Share

  66. HIRAISHI A, Kamiya K, Sugihara N, Komine M, et al
    A Case of Palmoplantar Psoriasis Successfully Treated With Tapinarof Cream.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70079.
    >> Share

  67. JIAO S, Su D, Si S, Zhang N, et al
    Risk Factors for Drug-Induced Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70063.
    >> Share

  68. ENDO M, Yamamoto T
    Lichen Nitidus in a Patient With Systemic Sarcoidosis.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70087.
    >> Share

  69. KOIKE Y, Morisaki H, Motooka D, Matsumoto M, et al
    Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
    >> Share


    J Invest Dermatol

  70. VAN EE A, Garza LA
    New Insights into the Neglected Disease Vulvar Lichen Sclerosus.
    J Invest Dermatol. 2025 Nov 21:S0022-202X(25)03416.
    >> Share

  71. LAN J, Jiang B, Zhang X, Xia Y, et al
    CD36-mediated long-chain fatty acids transport in keratinocytes promotes psoriasis-like skin inflammation through increasing mitochondrial reactive oxygen species.
    J Invest Dermatol. 2025 Nov 20:S0022-202X(25)03555.
    >> Share

  72. DASGUPTA R, Park PH, Wallace M, Marzula V, et al
    A CD206 targeting peptide exhibits preclinical therapeutic efficacy in cutaneous T-cell lymphoma.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03607.
    >> Share

  73. RAJA DAVID ISAC EB, Sigurbjornsdottir S, Dilshat R, Cornell RA, et al
    Phenotype switching in melanoma cells: MITF regulates the expression of CDH1 through E-boxes in an intronic region.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03605.
    >> Share

  74. WU CY, Vadhan A, Wei WY, Yu HS, et al
    Luteinizing Hormone Induces Murine Hair Loss through Transient Receptor Potential Canonical Channel-Mediated Cell Aging Responses: Implications for Female Pattern Hair Loss Pathogenesis.
    J Invest Dermatol. 2025;145:2989-2997.
    >> Share

  75. TOBIAS R, Kumar S, Liu J, Lenci N, et al
    Unrestrained MyD88 Signaling in A20-Deficient Keratinocytes Triggers T-Cell-Dependent Psoriatic Arthritis-Like Disease.
    J Invest Dermatol. 2025;145:2998-3010.
    >> Share

  76. QIN M, Evron E, Tran PT, Deng M, et al
    Immune Activation and Glycolytic Responses to Cutibacterium acnes Cell Wall Polysaccharides.
    J Invest Dermatol. 2025;145:3126-3137.
    >> Share

  77. LUKAS D, Liu X, Reibetanz M, Konen-Waisman S, et al
    Innate Lymphoid Cell 1- and NK Cell-Derived, Early IFNg Release Depends on ICER and Promotes Protection against Leishmania major Infection.
    J Invest Dermatol. 2025;145:3138-3144.
    >> Share

  78. QIU X, Feng Y, Mo X, Ju Q, et al
    Multi-Omics Analysis Identifies Genetic Mechanisms and Therapeutic Targets for Acne Vulgaris.
    J Invest Dermatol. 2025;145:3037-3050.
    >> Share

  79. NEEDLE CD, Brinks AL, Perez OD, Shapiro J, et al
    A Comprehensive Review of GWASs of Human Hair Traits.
    J Invest Dermatol. 2025;145:2964-2972.
    >> Share


    Lancet

  80. GUTTMAN-YASSKY E, Kabashima K, Worm M, Luna PC, et al
    Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.
    Lancet. 2025 Nov 25:S0140-6736(25)01865-3. doi: 10.1016/S0140-6736(25)01865.
    >> Share

  81. ATASH K, Boesjes CM, de Bruin-Weller MS
    Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.
    Lancet. 2025 Nov 25:S0140-6736(25)02152-X. doi: 10.1016/S0140-6736(25)02152.
    >> Share


    Mycoses

  82. WANG J, Gow NAR, Brewer MG
    Candida albicans Enhances Protease Activity and Activates MyD88-Dependent IL-1beta Production in Human Keratinocytes.
    Mycoses. 2025;68:e70133.
    >> Share

  83. CHEN SJ, Chen S, Wang Y
    Global Burden of Fungal Skin Diseases and Future Projections: An Analysis of the 2021 Global Burden of Disease Study.
    Mycoses. 2025;68:e70134.
    >> Share


    Plast Reconstr Surg

  84. KIM J, Lee DY, Lee KT, Mun GH, et al
    Foot Melanoma Reconstruction Using Refined Perforator Flap: Safety, Function, and Subregional Surgical Strategy.
    Plast Reconstr Surg. 2025 Nov 25. doi: 10.1097/PRS.0000000000012655.
    >> Share


    PLoS Biol

  85. MAO F, Wu S, Allison DB, He D, et al
    The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1.
    PLoS Biol. 2025;23:e3003490.
    >> Share


    PLoS One

  86. STUTZIN DONOSO F, Archer S, Walter FM, Morris S, et al
    CanRisk-GP protocol: A feasibility study of incorporating proactive multifactorial breast cancer risk assessment into general practice.
    PLoS One. 2025;20:e0336902.
    >> Share

  87. WOGAYEHU BT
    Self-reported prevalence of hand eczema and associated factors among hair dressers of Debre Berhan City in North Eastern Ethiopia.
    PLoS One. 2025;20:e0336974.
    >> Share

  88. VAN CAPPELLEN-VAN MALDEGEM SJM, Kruif A, Seidell JC, van de Poll-Franse LV, et al
    Determinants and timing of lifestyle changes in postmenopausal breast cancer survivors: A longitudinal qualitative study.
    PLoS One. 2025;20:e0337089.
    >> Share

  89. LI W, Wang X, Yu Q, Zhou W, et al
    Symptom network analysis in breast cancer patients: A scoping review.
    PLoS One. 2025;20:e0336793.
    >> Share

  90. ZENG J, Lin L, Ma Y, Huang W, et al
    Single-cell transcriptomics profiling reveals cellular origins and molecular drivers underlying melanoma brain metastasis.
    PLoS One. 2025;20:e0336502.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016